This site has now been archived and content is not being updated. |
You are here
Creating a genetic library to support drug development
COVID-19 Research Area(s): Diagnostics, Genomics & Transmission Dynamics, Vaccines & Treatments
Dr. Kurt Haas, professor in the department of cellular and physiological sciences at UBC, is receiving $172,414 from CIHR to examine how different genetic variants of the human ACE2 protein interact with the spike protein on the COVID-19 virus, SARS-CoV-2. Researchers in the Djavad Mowafaghian Centre for Brain Health will create genetic libraries of ACE2 variants, and test how the SARS-CoV-2 binds to them, which is how it infects host cells. Results may identify genetic contributions to disease expression, and this library will be available to test emerging drug therapies and aid efforts to develop novel therapeutics.
Post date:
Jun 25, 2020